Viewing Study NCT01709734


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-03-05 @ 6:13 AM
Study NCT ID: NCT01709734
Status: TERMINATED
Last Update Posted: 2023-03-15
First Post: 2012-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer
Sponsor: LTN PHARMACEUTICALS, INC.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostate cancer CRPC View